The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction (Q44472847)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction
scientific article

    Statements

    The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit